
Semaglutide found to have shocking benefit for liver disease patients in new study
Fox News
Breakthrough research shows semaglutide effectively reverses life-threatening liver disease MASH, demonstrating significant inflammation reduction in 62.9% of clinical trial participants.
"This is a major step forward in the field," said Arun Sanyal, M.D., director of the VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, in a video from VCU. "It provides patients with additional choices when we think about treating fatty liver disease." "I've been working with GLP-1 treatments for 16 years and these results are hugely exciting." Khloe Quill is a lifestyle production assistant with Fox News Digital. She and the lifestyle team cover a range of story topics including food and drink, travel, and health.
MASH is a severe form of metabolic dysfunction-associated steatotic liver disease (MASLD), which was previously known as non-alcoholic fatty liver disease, according to WebMD.

Pizza before tomatoes? Ancient Rome's version of America's favorite food looked nothing like today's
Ancient Rome pizza at Hungary restaurant features no tomatoes or mozzarella, using garum fish sauce and olive paste. Neverland Pizzeria's dish is limited-edition.












